Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire
*Planegg/Martinsried, **April 26, 2024.* Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology..
Scientific American
News and Video Search Results
News coverage
-
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
GlobeNewswire
-
Early Trauma Cuts Life Short For Squirrels, And Climate Change Could Make Matters Worse
Eurasia Review
-
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
GlobeNewswire
-
Brazil And Colombia: On A Consolidated Path Of Cooperation – OpEd
Eurasia Review
- More about:
Yukon
0 shares
1 views
You might like
Scientific American media coverage
Materials informatics Market Size to Worth USD 1,572.93 Million by 2033
GlobeNewswire
The global materials informatics market size is calculated at USD 252.9 million in 2024 and is estimated to be worth around USD..
-
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
PR Newswire Asia
-
International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18
GlobeNewswire
-
Zentek Provides ZenGUARD(TM) Business Update
Accesswire
-
Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
EQS Group
Advertisement
More coverage
Atos reports first quarter 2024 performance
GlobeNewswire
Press Release
*Atos reports first quarter 2024 performance*^*1*
*Q1 2024 Revenue €2,479m, down -2.6%..
-
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
GlobeNewswire
-
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
PR Newswire Asia
-
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
-
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
GlobeNewswire